ask="6.15"
ask_size="300"
average_daily_volume="231179"
bid="4.75"
bid_size="4000"
book_value="1.38"
change="-0.20"
change_from_200_day_moving_average="-1.01"
change_from_50_day_moving_average="-0.03"
change_from_52_week_high="-3.05"
change_From_52_week_low="1.05"
change_in_percent="-3.64%"
close="5.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.61"
ebitda="-55.83M"
eps_estimate_current_year="-1.25"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.09"
ex_dividend_date="N/A"
float_shares="42874000"
high="5.50"
high_52_weeks="8.35"
last_trade_date="1/19/2017"
last_trade_price="5.30"
last_trade_size="3433"
last_trade_time="4:00pm"
low="5.30"
low_52_weeks="4.25"
market_capitalization="307.08M"
moving_average_200_day="6.31"
moving_average_50_day="5.33"
name="Sorrento Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.00"
open="5.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-16.07%"
percent_change_from_50_day_moving_average="-0.65%"
percent_change_from_52_week_high="-36.53%"
percent_change_from_52_week_low="+24.71%"
previous_close="5.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.98"
price_per_sales="58.26"
revenue="5.47M"
shares_outstanding="57939000"
short_ratio="18.12"
stock_exchange="NCM"
symbol="SRNE"
volume="59960"
weeks_range_52="4.25 - 8.35"
